{"@context":"https:\/\/schema.org\/","@type":"CollectionPage","@id":"https:\/\/www.regionalcancercare.org\/news\/category\/brain-cancer\/#CollectionPage","headline":"Brain Cancer Category","description":"","url":"https:\/\/www.regionalcancercare.org\/news\/category\/brain-cancer\/","hasPart":[{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","headline":"Cancers Most Likely To Benefit From Targeted Monoclonal Immunotherapy","url":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","datePublished":"2020-04-21","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","height":600,"width":900},"keywords":["Treatments","Immunotherapy","targeted therapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/evaluating-the-state-of-the-primary-tumor\/","headline":"The \u2018Primary Tumor\u2019 and the Patient\u2019s Cancer Journey","url":"https:\/\/www.regionalcancercare.org\/news\/evaluating-the-state-of-the-primary-tumor\/","datePublished":"2020-03-24","dateModified":"2025-12-04","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/evaluating-the-state-of-the-primary-tumor\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctors-Talking-About-A-Patients-Cancer.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctors-Talking-About-A-Patients-Cancer.jpg","height":600,"width":900},"keywords":["Patient Education"]}],"about":["All Cancers","Brain Cancer","Prostate Cancer","Lung Cancer"]}